UNSPSC 51332870: Promazine hydrochloride

This classification denotes a phenothiazine and antipsychotic agent with the molecular formula C17H20N2S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U16EOR79U4, chemically known as 10h-phenothiazine-10-propanamine, n,n-dimethyl-, monohydrochloride but more generally known as promazine hydrochloride, which bears US NIH Compound Identifier 4926. European Medicines Agency schedules Promazine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04067MIG.

UNSPSC 51332870 Promazine hydrochloride, a Commodity code, shows limited recent state and local procurement activity directly aligned with the code's pharmaceutical scope. The single recent opportunity in the dataset—Seminole County, Florida's IFB60459723LAS—is tagged under this code but solicits naloxone and drug deactivation systems rather than promazine hydrochloride specifically. State and local governments purchasing under this code acquire pharmaceutical products for community health and emergency response programs, though the recent record does not clearly distinguish promazine procurement from broader pharmaceutical acquisitions.

Seminole County, a Florida county government, posted the representative recent opportunity on June 30, 2026, with a response deadline of July 26, 2023 (note: the posted date and due date span different years in the source, creating a temporal inconsistency in the record). The solicitation is an IFB for 1,900 units of naloxone and 800 drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, and includes FEMA funding contingent on federal compliance requirements. The procurement carries a two-year initial term with a one-year renewal option and imposes standard compliance obligations including drug-free workplace certification, E-Verify enrollment, and specified insurance coverage. Activity under this code appears concentrated in Florida with no additional geographic spread evident in the recent opportunities block. The limited data suggests that promazine hydrochloride procurement at state and local level may occur sporadically or under broader pharmaceutical aggregations rather than as a standalone commodity focus.